Development of a Novel, High-Level Protein Expression Platfrom Based on Plant Nectar
Department of Agriculture
Agency Tracking Number:
Solicitation Topic Code:
Small Business Information
NERP Technologies, Inc.
807 Hodge Avenue, Ames, IA, 50010
Socially and Economically Disadvantaged:
AbstractThe ability to produce high levels of therapeutic proteins at low costs could result in improved health care for large numbers of individuals. NERP seeks to create a new biopharmaceutical protein production platform that will have significant advantages by lowering the costs of production and of purification for therapeutic proteins. NERP is considering two potential therapeutic protein targets for expression, interferon-b1a and erythropoietin.
* information listed above is at the time of submission.